Skip to main content

U.S. Capital Wealth Advisors, LLC

Position in GILD — Gilead Sciences, Inc.

CIK 1808915 AUSTIN, TX

Position in GILD

as of Mar 31, 2026 · filed Apr 7, 2026
Position Value
$1,046,111
+$94,631 QoQ
Shares Held
7,506
-3.2% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Sep 2021
19 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in GILD Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Mar 31, 2026

U.S. Capital Wealth Advisors, LLC holds $125,986,971 across 13 Drug Manufacturers - General names. GILD ranks #11 (0.8% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in GILD

Export CSV
19 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $1,046,111 7,506
2025-12-31 $951,480 7,752
2025-09-30 $792,651 7,141
2025-06-30 $9,005,748 81,228
2025-03-31 $689,107 6,150
2024-12-31 $619,340 6,705
2024-09-30 $5,986,008 71,398
2024-06-30 $5,198,648 75,771
2024-03-31 $5,843,445 79,774
2023-12-31 $6,729,500 83,070
2023-09-30 $1,503,371 20,061
2023-06-30 $1,756,733 22,794
2023-03-31 $2,131,914 25,695
2022-12-31 $2,251,244 26,223
2022-09-30 $6,856,905 111,151
2022-06-30 $6,910,110 111,796
2022-03-31 $6,593,361 110,906
2021-12-31 $8,092,384 111,450
2021-09-30 $8,798,725 125,966